Sage Journals: Discover world-class research

Free access

Review article

First published 1999-12

Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom

Ole S Pedersen, Erik B Pedersen

Antiviral Chemistry and Chemotherapy

Open access

Research article

First published 2022-4

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Dannae Brown, Richard Kaplan, Marcelo Losso [...]

Antiviral Therapy

Retricted access

Research article

First published 2004-6

Emtricitabine: A Once-Daily Nucleoside Reverse Transcriptase Inhibitor

Krysten A Modrzejewski, Ronald A Herman

Annals of Pharmacotherapy

Retricted access

Research article

First published 2009-10

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Monica M Gaffney, Paul P Belliveau, Linda M Spooner

Annals of Pharmacotherapy

Free access

Research article

First published 1995-4

Characterization of the Antiviral Activity of Highly Substituted Pyrroles: A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor

T. Antonucci, J. S. Warmus, J. C. Hodges [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 1996-10

A Diarylsulphone Non-Nucleoside Reverse Transcriptase Inhibitor with a Unique Sensitivity Profile to Drug-Resistant Virus Isolates

R.W. Buckheit, V. Fliakas-Boltz, J.D. Russell [...]

Antiviral Chemistry and Chemotherapy

Free access

Other

First published 2009-11

Etravirine for HIV-I: Addressing the Limitations of the Nonnucleoside Reverse Transcriptase Inhibitor Class

Troy Grennan, Sharon Walmsley

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Free access

Review article

First published 2007-4

Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection

Mark A Wainberg, Pedro Cahn, Richard C Bethell [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 2021-1

Effects of Reverse Transcriptase Inhibitors on Proliferation,Apoptosis,and Migration in Breast Carcinoma Cells

Zülal Atlı Şekeroğlu, Vedat Şekeroğlu, Nihan Küçük

International Journal of Toxicology

Retricted access

Research article

First published 2007-05

Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity

International Journal of STD & AIDS

Search results